Dentists in Montchanin, DE Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. Daria Jean Stout Ryan, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Rockland Rd And Rt 100, Suite P1 Montchanin Mills, Montchanin, DE 19710 Phone: 302-654-1765 Fax: 302-777-1883 |
 Dr. Garrett Browne Lyons Jr., D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 100 West Rockland Road, Suite P-1, Montchanin, DE 19710 Phone: 302-654-1765 Fax: 302-777-1883 |
News Archive
New report reveals rapid growth in Vietnam pharmaceutical market
Vietnam healthcare market size, market segmentation by hospitals & clinics, diagnostic labs market, pharmaceutical market and medical devices market, The report also covers market in different aspects such as healthcare scenario in Vietnam, government and private spending on healthcare, cross comparison of healthcare sector of Vietnam with other Asia Pacific countries, mergers, acquisitions and funding in healthcare sector, investment model for setting up a hospital, snapshots of daycare centers and polyclinics, investment model for setting up a diagnostic laboratory, government regulations for launching a new drug, role of IT companies in Vietnam and comparative analysis of major players in each section.
Discovery of gene associated with narcolepsy
Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night. The gene has a known role in the immune system, which strongly suggests that autoimmunity, in which the immune system turns against the body's own tissues, plays an important role in the disorder.
Amgen and GlaxoSmithKline to collaborate on Denosumab for postmenopausal osteoporosis
Amgen and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosis (PMO) in Europe, Australia, New Zealand and Mexico once the product is approved in these countries.
Trimeris second-quarter royalty revenue decreases to $1.6 million
Trimeris, Inc., or the "Company," today announced financial results for the quarter ended June 30, 2010, reporting net income of $1.3 million, or $0.06 per share, which was unchanged from the quarter ended June 30, 2009. Comparisons of net income between the quarters ended June 30, 2010 and June 30, 2009 are affected by a one-time adjustment in the second quarter of 2009 that increased operating expenses for that period by $496,000.
Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting
Sucampo Pharma Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc., today presented additional clinical data for lubiprostone (Amitiza®) at GASTRO 2009 UEGF/WCOG, the joint meeting of the United European Gastroenterology Federation (UEGF), the World Gastroenterology Organisation (WGO), the World Organisation of Digestive Endoscopy (OMED) and the British Society of Gastroenterology (BSG), in London.
› Verified 6 days ago